Anavex Deferred Long Term Liab vs Total Stockholder Equity Analysis
AVXL Stock | USD 4.06 0.08 1.93% |
Anavex Life financial indicator trend analysis is way more than just evaluating Anavex Life Sciences prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Anavex Life Sciences is a good investment. Please check the relationship between Anavex Life Deferred Long Term Liab and its Total Stockholder Equity accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anavex Life Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.
Deferred Long Term Liab vs Total Stockholder Equity
Deferred Long Term Liab vs Total Stockholder Equity Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Anavex Life Sciences Deferred Long Term Liab account and Total Stockholder Equity. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Anavex Life's Deferred Long Term Liab and Total Stockholder Equity is 0.49. Overlapping area represents the amount of variation of Deferred Long Term Liab that can explain the historical movement of Total Stockholder Equity in the same time period over historical financial statements of Anavex Life Sciences, assuming nothing else is changed. The correlation between historical values of Anavex Life's Deferred Long Term Liab and Total Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Deferred Long Term Liab of Anavex Life Sciences are associated (or correlated) with its Total Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Stockholder Equity has no effect on the direction of Deferred Long Term Liab i.e., Anavex Life's Deferred Long Term Liab and Total Stockholder Equity go up and down completely randomly.
Correlation Coefficient | 0.49 |
Relationship Direction | Positive |
Relationship Strength | Weak |
Deferred Long Term Liab
Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.Total Stockholder Equity
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.Most indicators from Anavex Life's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Anavex Life Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anavex Life Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. At this time, Anavex Life's Selling General Administrative is quite stable compared to the past year. Issuance Of Capital Stock is expected to rise to about 47.1 M this year, although Enterprise Value Over EBITDA will most likely fall to (7.39).
2021 | 2022 | 2023 | 2024 (projected) | Tax Provision | 358.5K | 7K | 8.1K | 7.6K | Interest Income | 947.0K | 6.5M | 7.5M | 7.9M |
Anavex Life fundamental ratios Correlations
Click cells to compare fundamentals
Anavex Life Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Anavex Life fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 34.5M | 161.6M | 152.7M | 154.4M | 177.5M | 186.4M | |
Other Current Liab | 3.3M | 5.6M | 5.9M | 7.3M | 8.4M | 8.8M | |
Total Current Liabilities | 7.3M | 10.8M | 10.2M | 12.5M | 14.4M | 15.1M | |
Total Stockholder Equity | 27.2M | 150.8M | 142.5M | 141.9M | 163.1M | 171.3M | |
Net Debt | (29.2M) | (152.1M) | (149.2M) | (151.0M) | (135.9M) | (129.1M) | |
Retained Earnings | (159.7M) | (197.6M) | (245.6M) | (293.1M) | (263.8M) | (250.6M) | |
Cash | 29.2M | 152.1M | 149.2M | 151.0M | 173.7M | 182.4M | |
Cash And Short Term Investments | 29.2M | 152.1M | 149.2M | 151.0M | 173.7M | 182.4M | |
Common Stock Total Equity | 52.7K | 62.0K | 75.9K | 77.9K | 89.6K | 94.1K | |
Common Stock Shares Outstanding | 58.2M | 69.8M | 76.9M | 79.8M | 91.8M | 96.3M | |
Liabilities And Stockholders Equity | 34.5M | 161.6M | 152.7M | 154.4M | 177.5M | 186.4M | |
Other Stockholder Equity | 186.9M | 348.3M | 388.0M | 434.8M | 500.1M | 525.1M | |
Total Liab | 7.3M | 10.8M | 10.2M | 12.5M | 14.4M | 15.1M | |
Total Current Assets | 34.5M | 161.6M | 152.7M | 154.4M | 177.5M | 186.4M | |
Common Stock | 62.0K | 75.9K | 77.9K | 82K | 94.3K | 99.0K | |
Accounts Payable | 4.0M | 4.7M | 3.8M | 4.3M | 5.0M | 5.2M | |
Other Current Assets | 443.8K | 355.5K | 354.2K | 653K | 751.0K | 495.2K | |
Non Current Liabilities Total | 3.3M | 5.6M | 4.3M | 7.3M | 8.4M | 8.8M | |
Net Receivables | 4.8M | 9.1M | 3.2M | 2.7M | 3.1M | 2.1M | |
Net Tangible Assets | 27.2M | 150.8M | 142.5M | 141.9M | 163.1M | 171.3M | |
Retained Earnings Total Equity | (133.4M) | (159.7M) | (197.6M) | (245.6M) | (221.0M) | (210.0M) | |
Capital Surpluse | 153.6M | 186.9M | 348.3M | 388.0M | 446.2M | 468.5M | |
Net Invested Capital | 27.2M | 150.8M | 142.5M | 141.9M | 163.1M | 82.9M | |
Net Working Capital | 27.2M | 150.8M | 142.5M | 141.9M | 163.1M | 82.9M | |
Capital Stock | 62.0K | 75.9K | 77.9K | 82K | 94.3K | 72.7K |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Anavex Life Sciences using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anavex Life Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Complementary Tools for Anavex Stock analysis
When running Anavex Life's price analysis, check to measure Anavex Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anavex Life is operating at the current time. Most of Anavex Life's value examination focuses on studying past and present price action to predict the probability of Anavex Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anavex Life's price. Additionally, you may evaluate how the addition of Anavex Life to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
Is Anavex Life's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anavex Life. If investors know Anavex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anavex Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.50) | Return On Assets (0.20) | Return On Equity (0.29) |
The market value of Anavex Life Sciences is measured differently than its book value, which is the value of Anavex that is recorded on the company's balance sheet. Investors also form their own opinion of Anavex Life's value that differs from its market value or its book value, called intrinsic value, which is Anavex Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anavex Life's market value can be influenced by many factors that don't directly affect Anavex Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anavex Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Anavex Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anavex Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.